Click any annotated section or its icon to see analysis.
Referenced Laws
chapter 17
section 1720L
21 U.S.C. 355
42 U.S.C. 262
Section 1
1. Short title This Act may be cited as the Access to Contraception Expansion for Veterans Act or the ACE Veterans Act.
Section 2
2. Full-year supply of contraceptive pills, transdermal patches, vaginal rings, and other contraceptive products Subchapter II of chapter 17 of title 38, United States Code, is amended by inserting after section 1720L the following new section: The Secretary shall ensure that a veteran who is enrolled in the system of annual patient enrollment under section 1705 of this title and to whom a medical provider of the Department prescribes contraceptive pills, transdermal patches, vaginal rings, or other contraceptive products may elect to fill such prescription as a full-year supply. A medical provider of the Department who prescribes to a veteran contraceptive pills, transdermal patches, vaginal rings, or other contraceptive products shall notify the veteran of the option to fill the prescription as a full-year supply. In this section, the term contraceptive product means any drug, device, or biological product intended for use in the prevention of pregnancy, whether specifically intended to prevent pregnancy or for other health needs, that is approved, cleared, authorized, or licensed under section 505, 510(k), 513(f)(2), 515, or 564 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355, 360(k), 360c(f)(2), 360e, 360bbb–3) or section 351 of the Public Health Service Act (42 U.S.C. 262). The table of sections at the beginning of such chapter is amended by inserting after the item relating to section 1720L the following new item: 1720M.Full-year supply of contraceptive pills, transdermal patches, vaginal rings, and other contraceptive products
(a)Availability of full-Year supplyThe Secretary shall ensure that a veteran who is enrolled in the system of annual patient enrollment under section 1705 of this title and to whom a medical provider of the Department prescribes contraceptive pills, transdermal patches, vaginal rings, or other contraceptive products may elect to fill such prescription as a full-year supply. (b)NoticeA medical provider of the Department who prescribes to a veteran contraceptive pills, transdermal patches, vaginal rings, or other contraceptive products shall notify the veteran of the option to fill the prescription as a full-year supply.
(c)Contraceptive product definedIn this section, the term contraceptive product means any drug, device, or biological product intended for use in the prevention of pregnancy, whether specifically intended to prevent pregnancy or for other health needs, that is approved, cleared, authorized, or licensed under section 505, 510(k), 513(f)(2), 515, or 564 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355, 360(k), 360c(f)(2), 360e, 360bbb–3) or section 351 of the Public Health Service Act (42 U.S.C. 262).. 1720M. Full-year supply of contraceptive pills, transdermal patches, vaginal rings, and other contraceptive products..
Section 3
1720M. Full-year supply of contraceptive pills, transdermal patches, vaginal rings, and other contraceptive products The Secretary shall ensure that a veteran who is enrolled in the system of annual patient enrollment under section 1705 of this title and to whom a medical provider of the Department prescribes contraceptive pills, transdermal patches, vaginal rings, or other contraceptive products may elect to fill such prescription as a full-year supply. A medical provider of the Department who prescribes to a veteran contraceptive pills, transdermal patches, vaginal rings, or other contraceptive products shall notify the veteran of the option to fill the prescription as a full-year supply. In this section, the term contraceptive product means any drug, device, or biological product intended for use in the prevention of pregnancy, whether specifically intended to prevent pregnancy or for other health needs, that is approved, cleared, authorized, or licensed under section 505, 510(k), 513(f)(2), 515, or 564 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355, 360(k), 360c(f)(2), 360e, 360bbb–3) or section 351 of the Public Health Service Act (42 U.S.C. 262).